Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
PSQL heads into the second week of October with a striking contradiction at its centre: short sellers are retreating fast while the cost to borrow their positions has never been higher in recent memory.
The stock gained 14% over the past week and 6% on Wednesday alone, closing at $7.26. That rebound follows a difficult month, with the shares still down about 9% from 30 days ago. The tension between a recovering price, a rapidly shrinking short position, and borrow costs running above 240% annually makes this one of the more charged setups in the small-cap quantum space right now.
The borrow market tells an unusual story for a stock where short sellers are actually pulling back. Shorts have fallen by 35% over the past week to around 232,000 shares, their lowest level in the 30-day history available, after peaking near 684,000 shares in mid-September. Yet the cost to borrow has climbed to 241% annualised, up 8% on the week, and the contrast with late August is stark: borrow cost was below 15% on August 31 and under 4% a few days before that. The dramatic repricing appears to coincide with the stock's Nasdaq listing and the sudden appetite for borrows that followed. Availability has loosened considerably to 318%, well above the tightest reading of 89% recorded on September 9, so the lending pool is not under stress. Borrow is expensive, but it is accessible. Positioning looks costly rather than constrained.
The analyst community has moved decisively in one direction since listing. Four separate initiations have landed in the past three weeks, all with Buy ratings. StoneX started coverage on October 6 with a $15 target. Needham opened at $16 a week earlier. Canaccord Genuity, which initiated at $16 on September 22, reaffirmed that view six days later. Roth Capital was the outlier on price, setting a $20 target in early September. The mean target across the group is $15.25, roughly double the current price of $7.26, though it is worth noting this is a recently listed company with no established trading history and a single institutional holder on record. The bull case centres on seven quantum processing units already deployed, booked and awarded business of around €70.4 million, and a neutral-atom architecture that analysts argue can generate revenue from analogue workloads today while preserving a path to fault-tolerant computing. Bears point to €4.9 million of first-half 2026 revenue against an operating loss of €59.2 million and a $250 million convertible financing carrying a 10% cash coupon and PIK provisions that create a substantial dilution overhang.
The ownership register is worth examining closely, given its activist dimension. Bpifrance Participations filed a Schedule 13D on September 3, disclosing an 11.4% stake of 24.5 million shares. A Schedule 13D signals active rather than passive intent, and Bpifrance is France's state-backed investment bank, making this a strategically significant holder for a French quantum computing company now listed in the United States. Two further 13G passive filings landed on October 7: Quantonation Ventures, a specialist quantum-focused fund, disclosed 11.5%, and Investiqo disclosed 5.8%. Inflection Point Fund I filed a 7% 13G in early September. Together, these four holders account for more than 36% of shares outstanding as disclosed. As always with 13D/G filings, stakes are as-last-disclosed around the 5% threshold, and holders dropping below that level may not file again.
The one earnings datapoint available offers a cautionary note on post-announcement moves. The September 24 results triggered a 6.4% one-day decline and a 16.2% five-day decline. The next event is not expected until December 24, leaving roughly 11 weeks before the market gets another fundamental update.
What to watch: whether the cost to borrow stabilises or continues its month-long drift lower from its September peak above 340%, and whether the cluster of freshly initiated analyst coverage translates into any broadening of the institutional holder base beyond the current register of one.
See the live data behind this article on ORTEX.
Open PSQL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
